9 परिणाम
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a method of inhibiting protein kinase C function and to compounds and compositions suitable for use in such a method.
2. Background Information
In mouse skin, phorbol esters exert tumor promoting, inflammatory,
2. TECHNICAL FIELD
The present disclosure relates to analogs and derivatives of phorbol compounds, their synthesis, and methods of using the compounds.
3. BACKGROUND
While highly active antiretroviral therapy (HAART) is helping many people with HIV/AIDS live longer, healthier lives, these
2. TECHNICAL FIELD
The present disclosure relates to analogs and derivatives of phorbol compounds, their synthesis, and methods of using the compounds.
3. BACKGROUND
While highly active antiretroviral therapy (HAART) is helping many people with HIV/AIDS live longer, healthier lives, these
BACKGROUND
1. Technical Field
The invention is in the fields of drug therapy; more specifically, the invention encompasses a protein for immunosuppression.
2. The Prior Art
The central nervous system (CNS) actively maintains immune privilege (Carson and Sutcliffe, 1999; Fabry et al., 1994), in part
BACKGROUND
Protein kinase C (also known as "calcium/phospholipid-dependent protein kinase", "PKC" or C-kinase") is a family of very closely related enzymes; one or more members of the protein kinase C family are found in nearly all animal tissues and animal cells that have been examined. The
TECHNICAL FIELD OF THE INVENTION
This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells.
This invention
TECHNICAL FIELD OF THE INVENTION
This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells.
This invention
TECHNICAL FIELD OF THE INVENTION
This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells.
This invention
TECHNICAL FIELD OF THE INVENTION
This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells.
This invention